GSK Investigational Site

Longwood, Florida 32779

0 studies enrolling now · 10 studies all time

What they study most

Asthma, Hypertriglyceridemia, Hypertrophy, Left Ventricular, Irritable Bowel Syndrome (IBS), Irritable Colon, Neoplasms, Prostate, Pulmonary Disease, Chronic Obstructive, Systemic Lupus Erythematosus

Studies at this site

• Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) — Completed
• A Randomized Study, Comparing Fluticasone Furoate/Umeclidinium/Vilanterol (FF/UMEC /VI) Single Inhaler Triple Therapy, Versus Multiple Inhaler Therapy (Budesonide/Formoterol Plus Tiotropium) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• ARI103094-Follow-Up Study for REDUCE Study Subjects — Completed
• Survival Of Subjects With Chronic Obstructive Pulmonary Disease (COPD) — Completed
• The CLEVER Study - Coreg And Left Ventricular Mass Regression — Completed
• Study In Subjects With COPD (Chronic Obstructive Pulmonary Disease) — Completed
• "REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk — Completed
• GSK BHR Study (Sont - Second Study) — Completed
• Study Of Women With Severe Diarrhea-Predominant Irritable Bowel Syndrome Having Failed Conventional Therapy — Completed
• A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™ — Completed